


To achieve capital growth whilst maintaining a reasonable yield through a diversified Investments largely in equity markets with a bias towards UK and international equities, fixed income securities issued by governments, corporations and bank deposits.
| Name | % Net Assets |
|---|---|
| HSBC | 6.3% |
| HSBC | 5.4% |
| GlaxoSmithKline | 4.1% |
| Imperial Tobacco | 3.5% |
| Unilever | 3.5% |
| Standard Chartered | 3.4% |
| BP | 3.3% |
| BG | 3.2% |
| BHP Billiton | 3.0% |
| Anglo American | 2.8% |
| Key | % Net Assets |
|---|---|
| 6.3% | |
| 5.4% | |
| 4.1% | |
| 3.5% | |
| 80.7% |
| Date | 19-Aug-2025 |
|---|---|
| NAV | 201.75p |
| Currency | GBP |
| Change | 0.39p |
| % | 0.19% |
| YTD change | 4.65p |
| YTD % | 2.36% |
| Fund Inception | 01/06/1999 |
|---|---|
| Fund Manager | Alan Custis / Gabrielle Boyle / Ian Smart and teams |
| TER | 1.55 (31-Mar-2014) |
| Minimum Investment | |
|---|---|
| Initial | £2000 |
| Additional | £500 |
| Savings | £75 |
| Charges | |
|---|---|
| Initial | 3.75% |
| Annual Mang't | 1.25% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.01 |
| Sharpe ratio | 0.06 |
You are here: research